Search
for
Sort by
Research 241–270 of 1000+
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- The Role of Janus Kinase Inhibitors in Dermatology
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience
- Alopecia Areata: JAK Inhibitors—PRP and Exosomes
- Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- A review of Janus kinase inhibitor use in scarring alopecia
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Ritlecitinib: First Approval
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review
- New drugs under investigation for the treatment of alopecias